Medtronic on Aug. 22 posted $7.7 billion in revenue for the first quarter of fiscal year 2024.

Wenzel Spine earned FDA clearance for the PrimaLOK SP system, the devicemaker said Aug. 22.

The first 50 cases with Kleiner Device Labs' KG2 Surge flow-thru interbody system were completed, the devicemaker said Aug. 17.

ZimVie is expanding its partnership with Brainlab to include co-marketing, according to an Aug. 17 news release. 

Stryker CEO, Kevin Lobo, won the Ellis Island Medal of Honor for his career at Stryker, CBS affiliate WWMT reported Aug. 15.

Spine devicemaker 4WEB Medical launched its cervical spine plating solution, the company said Aug. 15.

Orthopedic and spine device manufacturer and distributor Fuse Medical has released its second quarter financial results, showing a net revenue of $5 million, up seven percent from the same quarter last year. 

Vertos Medical, a company focused on minimally invasive spine surgery, promoted two leaders to C-suite roles.

Viseon's 4K MaxView system for minimally invasive spine surgery visualization has launched, and the first clinical cases were completed, the company said Aug. 15.

Stephen Smith, MD, of Beacon Health System Memorial Hospital in South Bend, Ind., performed the first clinical case with Happe Spine's Integrate-C interbody fusion system.

Here are four spine device approvals since June 1:

ZimVie earned FDA approval for its new version of the Mobi-C cervical disc, the devicemaker said Aug. 10.

Neuralink earned a $280 million series D funding round, the company said in an Aug. 7 tweet.

Curiteva received FDA 510(k) approval for its pedicle and sacroiliac joint navigation instruments, the medtech company said Aug. 8.

Alphatec posted $117 million in second quarter sales.

SynerFuse named Bill Koschak as CFO, the company said Aug. 7.

Anne-Françoise Nesmes, CFO of medical technology company Smith + Nephew, will step down from the role during the second quarter of 2024. 

Stryker, Johnson & Johnson and Zimmer Biomet posted their second quarter financial results for 2023, and data on their orthopedic sales.

Globus Medical on Aug. 3 posted second quarter sales of $291.6 million.

NuVasive's CEO Chris Barry remains confident the spine company will meet its planned merger with Globus Medical on schedule, he said in an Aug. 2 earnings call.